Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2020

View Archived Issues

NeuroTheryX and Cyclica launch NineteenGale Therapeutics

Small-molecule DNA-binding compound specifically induces CAG-repeat contractions in vivo

Pilot trial of botanical topical lotion CG-428 for permanent chemotherapy-induced alopecia

Inhibiting the aggregation of amyloid proteins improves neurodegeneration in an LSD model

New knockout mice models and gene replacement therapy for Barth syndrome

Study links GABA, mitochondria, social defects

OliX Pharmaceuticals to advance siRNA preclinical therapeutic candidate against COVID-19

GlaxoSmithKline patents new BRD4 inhibitors

Aerie Pharmaceuticals discloses new kinase modulators

Korean researchers identify NONO inhibitors

Shattuk Labs describes new chimeric proteins for cancer

Drink plenty of water: Sugar shortens lifespan via dehydration, not metabolic defects

New compounds for HBV infection presented by Assembly Biosciences

Preclinical characterization of novel thermoneutral TRPV1 inhibitor GRTE-16523

DB-020 demonstrates promising safety and PK in healthy subjects

Health Canada grants first global regulatory approval for Cabenuva

WEG-232 reduces erlotinib-induced facial rash and hair loss in rats

Studies show fluorescent PARP-1 inhibitor can detect oropharyngeal and esophageal cancer

Celltrion announces key milestones in COVID-19 efforts

U.S. complete response letter issued for empagliflozin for type 1 diabetes

Precision Biosciences begins phase I/IIa study of PBCAR-20-A for relapsed/refractory NHL and CLL/SLL

Harpoon initiates phase I/II study of HPN-217 in relapsed or refractory multiple myeloma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...